SMN1 and pediatric acute respiratory distress syndrome: While recent advances in disease modifying treatments (DMTs) have improved survival and quality of life in these patients, the management and outcomes of pediatric acute respiratory distress syndrome (pARDS) in SMA-1 children have not yet been described.